ArticleLung cancer (Amsterdam, Netherlands)2017

Emergence of FGFR3-TACC3 fusions as a potential by-pass resistance mechanism to EGFR tyrosine kinase inhibitors in EGFR mutated NSCLC patients.

Sai-Hong Ignatius Ou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.